Oracle Database@Google Cloud Adds New Oracle AI Database Services, Additional Regions, and Groundbreaking Partner Program
Oracle Autonomous AI Lakehouse, Oracle Exadata Database Service on Exascale Infrastructure, and Oracle Base Database Service are now generally available Powerful... Read more.
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
PHOENIX, Oct. 14, 2025 /PRNewswire/ — Trinity Capital Inc. (Nasdaq: TRIN) (the “Company”), a leading alternative asset manager, today announced... Read more.
Chamberlain Group Sets the Smart Garage as New Industry Standard with Updated Line of Smart Video-Enabled Garage Door Openers
OAK BROOK, Ill., Oct. 14, 2025 /PRNewswire/ — Chamberlain Group (CG), a Blackstone portfolio company and a global leader in intelligent access and monitoring... Read more.
Allegis Global Solutions Named a Leader and Star Performer on Everest Group’s 2025 RPO PEAK Matrix® Assessment for the Asia Pacific Region
HANOVER, Md., Oct. 14, 2025 /PRNewswire/ — Allegis Global Solutions, the global leader in workforce solutions, was acknowledged as a Leader and Star Performer... Read more.
Oracle Autonomous AI Lakehouse Enables Open, Interoperable Data Access Across Multi-Platform, Multicloud Environments
Combines Oracle Autonomous AI Database with vendor-independent Apache Iceberg enabling customers to run AI and analytics securely on all their data Now available... Read more.
STAND 8 Achieves ISO 27001 and SOC 2 Type II Certifications, Strengthening Enterprise-Grade Trust and Security
LOS ANGELES, Oct. 14, 2025 /PRNewswire/ — STAND 8, the people-first enterprise technology concierge renowned for its five-star, white-glove service, today... Read more.
Oracle Cloud Infrastructure Enables More Customers to Rapidly Deploy AI and Cloud Services
New OCI Dedicated Region25 delivers OCI’s 200+ AI and cloud services directly into customer data centers with a reduced physical footprint LAS VEGAS, Oct.... Read more.
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
Safety primary endpoint achieved Median treatment duration of 4 months with a range of 2 to 12 months and three patients remain on trial RECIST data with apparent... Read more.
Glide Identity unveils SIM-anchored, phishing-resistant identity solutions at Authenticate 2025
Collaborating with industry leaders, including T-Mobile and Verizon, Google Cloud, and the Android ecosystem, Glide aligns with FIDO Alliance’s mission for... Read more.
Coveo Unlocks Custom Actions for AI Agents
Improved precision, accuracy and relevance now grounds Agentforce with the best enterprise-approved knowledge MONTREAL, Oct. 14, 2025 /PRNewswire/ – Coveo,... Read more.